These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11140334)

  • 1. Self-administration of two long-acting monoamine transport blockers in rhesus monkeys.
    Lile JA; Morgan D; Freedland CS; Sinnott RS; Davies HM; Nader MA
    Psychopharmacology (Berl); 2000 Nov; 152(4):414-21. PubMed ID: 11140334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics.
    Lile JA; Wang Z; Woolverton WL; France JE; Gregg TC; Davies HM; Nader MA
    J Pharmacol Exp Ther; 2003 Oct; 307(1):356-66. PubMed ID: 12954808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the dopamine reuptake inhibitor PTT on reinstatement and on food- and cocaine-maintained responding in rhesus monkeys.
    Lile JA; Morgan D; Birmingham AM; Davies HM; Nader MA
    Psychopharmacology (Berl); 2004 Jul; 174(2):246-53. PubMed ID: 14735291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reinforcing and discriminative stimulus effects of the novel cocaine analog 2beta-propanoyl-3beta-(4-tolyl)-tropane in rhesus monkeys.
    Nader MA; Grant KA; Davies HM; Mach RH; Childers SR
    J Pharmacol Exp Ther; 1997 Feb; 280(2):541-50. PubMed ID: 9023262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
    Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evaluation of the reinforcing effects of the novel cocaine analog 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) in rhesus monkeys.
    Birmingham AM; Nader SH; Grant KA; Davies HM; Nader MA
    Psychopharmacology (Berl); 1998 Mar; 136(2):139-47. PubMed ID: 9551770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reinforcing efficacy of the dopamine reuptake inhibitor 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) as measured by a progressive-ratio schedule and a choice procedure in rhesus monkeys.
    Lile JA; Morgan D; Birmingham AM; Wang Z; Woolverton WL; Davies HM; Nader MA
    J Pharmacol Exp Ther; 2002 Nov; 303(2):640-8. PubMed ID: 12388646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.
    Wilcox KM; Lindsey KP; Votaw JR; Goodman MM; Martarello L; Carroll FI; Howell LL
    Synapse; 2002 Jan; 43(1):78-85. PubMed ID: 11746736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-administration of cocaine analogs by rats.
    Roberts DC; Phelan R; Hodges LM; Hodges MM; Bennett B; Childers S; Davies H
    Psychopharmacology (Berl); 1999 Jun; 144(4):389-97. PubMed ID: 10435412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.
    Letchworth SR; Nader MA; Smith HR; Friedman DP; Porrino LJ
    J Neurosci; 2001 Apr; 21(8):2799-807. PubMed ID: 11306632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys.
    Negus SS; Mello NK; Blough BE; Baumann MH; Rothman RB
    J Pharmacol Exp Ther; 2007 Feb; 320(2):627-36. PubMed ID: 17071819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First- versus last-session substitution: an evaluation of the reinforcing effects of cocaine and the cocaine analogue 2beta-propanoyl-3beta-(4-tolyl)-tropane.
    Lile JA; Morgan D; Nader MA
    Exp Clin Psychopharmacol; 2000 Aug; 8(3):424-33. PubMed ID: 10975634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged dopamine and serotonin transporter inhibition after exposure to tropanes.
    Bennett BA; Hollingsworth CK; Martin RS; Childers SR; Ehrenkaufer RE; Porrino LJ; Davies HM
    Neuropharmacology; 1998; 37(1):123-30. PubMed ID: 9680265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys.
    Howell LL; Carroll FI; Votaw JR; Goodman MM; Kimmel HL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):757-65. PubMed ID: 17105829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the behavioral effects of the repeated administration of PTT, 2beta-propanoyl-3beta-(4-tolyl)tropane and cocaine.
    Freedland CS; Smith HR; Hart SL; Daunais JB; Davies HM; Porrino LJ
    Brain Res; 2000 Jun; 869(1-2):98-104. PubMed ID: 10865063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
    Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
    J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine.
    Woolverton WL; Wang Z
    Eur J Pharmacol; 2004 Feb; 486(3):251-7. PubMed ID: 14985046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a tropane radioligand, [(3)H]2beta-propanoyl-3beta-(4-tolyl) tropane ([(3)H]PTT), for dopamine transport sites in rat brain.
    Letchworth SR; Smith HR; Porrino LJ; Bennett BA; Davies HM; Sexton T; Childers SR
    J Pharmacol Exp Ther; 2000 May; 293(2):686-96. PubMed ID: 10773045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.
    Gill KE; Pierre PJ; Daunais J; Bennett AJ; Martelle S; Gage HD; Swanson JM; Nader MA; Porrino LJ
    Neuropsychopharmacology; 2012 Nov; 37(12):2555-65. PubMed ID: 22805600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reduced rate of in vivo dopamine transporter binding is associated with lower relative reinforcing efficacy of stimulants.
    Wee S; Carroll FI; Woolverton WL
    Neuropsychopharmacology; 2006 Feb; 31(2):351-62. PubMed ID: 15957006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.